Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „duloxetine“
Suchtreffer
Begriffe & Kennungen
Duloxetine Viatris (previously Duloxetine Mylan) · 4.3 · Duloxetine Viatris should not be used in combination with fluvoxamine, ciprofloxacin or enoxacin (i.e. potent
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.3 · Liver disease resulting in hepatic impairment (see section 5.2).
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.3 · Severe renal impairment (creatinine clearance <30 ml/min) (see section 4.4).
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · 8 In rare cases, serotonin syndrome has been reported in patients using SSRIs/SNRIs concomitantly with seroton
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · Antacids and H2 antagonists Co-administration of duloxetine with aluminium- and magnesium-containing antacids
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · Anticoagulants and antiplatelet agents Caution should be exercised when duloxetine is combined with oral antic
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · Because CYP1A2 is involved in duloxetine metabolism, concomitant use of duloxetine with potent inhibitors of C
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · CNS medicinal products
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · Due to the risk of serotonin syndrome, duloxetine should not be used in combination with non-selective irrever
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · Effect of duloxetine on other medicinal products
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · Effects of other medicinal products on duloxetine
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · Inducers of CYP1A2 Population pharmacokinetic analyses have shown that smokers have almost 50% lower plasma co
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · Inhibitors of CYP1A2
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · Medicinal products metabolised by CYP1A2 The pharmacokinetics of theophylline, a CYP1A2 substrate, were not si
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · Medicinal products metabolised by CYP2D6 Duloxetine is a moderate inhibitor of CYP2D6. When duloxetine was adm
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · Monoamine oxidase inhibitors (MAOIs)
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.5 · Oral contraceptives and other steroidal agents Results of in vitro studies demonstrate that duloxetine does no
Eintrag öffnen